Find Clinical Trials | Cedars-Sinai

319 results found

Other

DSA Project

The primary objective of the study is to apply novel immuno-phenotyping techniques on heart transplant recipients with dnDSA in the presence and absence of concomitant rejection in order to identify unique characteristics of pathological DSAs ...

Other Hematopoietic

Addition of Targeted Therapeutic Agents to Tafasitamab-Based Therapy in Large B-Cell Lymphoma

This study focuses on patients with relapsed or refractory large b-cell lymphoma (LBCL). Relapsed means the LBCL has returned after it responded to treatment; refractory means the LBCL did not respond to earlier treatment. The ...

Non-Hodgkin's Lymphoma

IMPT-314 in Aggressive B-Cell Non-Hodgkin Lymphoma

The purpose of this study is to evaluate experimental gene-modified immune cells called IMPT-314 for the treatment of lymphomas that have either come back after treatment or have stopped responding to treatment. IMPT-314 is a ...

Anus, Brain and Nervous System, Breast, Cervix, Colon, Esophagus

LCB84 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumors

This study focuses on individuals who have metastatic cancer (cancer that has spread) that has not responded to standard treatments or for whom no effective therapy is available. The purpose of the study is to ...

Lung

Tepotinib with or Without Ramucirumab in Stage IV or Recurrent Non-Small Cell Lung Cancer

The purpose of this study is to determine whether the combination of 2 drugs, tepotinib and ramucirumab, lowers the chance of cancer growing or spreading in people with advanced non-small cell lung cancer. Researchers will ...